{"cdcTestId":"2013-0491","testcaseName":"#2 @ 16 years, MCV4","vaccineGroup":"MCV","evaluationTestType":"Age: At Recommended","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2006-10-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2017-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2017-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2017-11-15T07:16:50.354","generalDescription":"This test case describes when dose #1 and dose #2 of a Mening vaccine are administered at the recommended ages (11 and 16 years), that the doses are considered valid.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}